309 related articles for article (PubMed ID: 36207413)
21. The Actual Role of LDH as Tumor Marker, Biochemical and Clinical Aspects.
Jurisic V; Radenkovic S; Konjevic G
Adv Exp Med Biol; 2015; 867():115-24. PubMed ID: 26530363
[TBL] [Abstract][Full Text] [Related]
22. Lactate dehydrogenase is correlated with clinical stage and grade and is downregulated by si‑SAΤB1 in ovarian cancer.
Xiang J; Zhou L; Zhuang Y; Zhang J; Sun Y; Li S; Zhang Z; Zhang G; He Y
Oncol Rep; 2018 Nov; 40(5):2788-2797. PubMed ID: 30132561
[TBL] [Abstract][Full Text] [Related]
23. The impact of hypoxia on the activity of lactate dehydrogenase in two different pre-clinical tumour models.
Lukacova S; Sørensen BS; Alsner J; Overgaard J; Horsman MR
Acta Oncol; 2008; 47(5):941-7. PubMed ID: 17906983
[TBL] [Abstract][Full Text] [Related]
24. [Significance of lactate dehydrogenase measurements in diagnosis of malignancies].
Augoff K; Grabowski K
Pol Merkur Lekarski; 2004 Dec; 17(102):644-7. PubMed ID: 15771142
[TBL] [Abstract][Full Text] [Related]
25. Lactate Dehydrogenase Prior to Transarterial Hepatic Chemoperfusion Predicts Survival and Time to Progression in Patients with Uveal Melanoma Liver Metastases.
Ludwig J; Haubold J; Heusner TA; Bauer S; Siveke JT; Richly H; Wetter A; Umutlu L; Theysohn JM
Rofo; 2021 Jun; 193(6):683-691. PubMed ID: 33348383
[TBL] [Abstract][Full Text] [Related]
26. Indoleamine 2,3 dioxygenase as a prognostic and follow-up marker in melanoma. A comparative study with LDH and S100B.
de Lecea MV; Palomares T; Al Kassam D; Cavia M; Geh JLC; de Llano P; Muñiz P; Armesto D; Martinez-Indart L; Alonso-Varona A
J Eur Acad Dermatol Venereol; 2017 Apr; 31(4):636-642. PubMed ID: 27633490
[TBL] [Abstract][Full Text] [Related]
27. Serum parameters as prognostic biomarkers in a real world cancer patient population treated with anti PD-1/PD-L1 therapy.
Minichsdorfer C; Gleiss A; Aretin MB; Schmidinger M; Fuereder T
Ann Med; 2022 Dec; 54(1):1339-1349. PubMed ID: 35535695
[TBL] [Abstract][Full Text] [Related]
28. S-100B: a stronger prognostic biomarker than LDH in stage IIIB-C melanoma.
Wevers KP; Kruijff S; Speijers MJ; Bastiaannet E; Muller Kobold AC; Hoekstra HJ
Ann Surg Oncol; 2013 Aug; 20(8):2772-9. PubMed ID: 23512078
[TBL] [Abstract][Full Text] [Related]
29. [Clinical significance of erythrocyte sedimentation rate, C-reactive protein and serum lactate dehydrogenase levels in the diagnosis, prognosis and treatment monitoring of children suffering from cancer].
Bień E; Balcerska A
Med Wieku Rozwoj; 2004; 8(4 Pt 2):1081-9. PubMed ID: 15951603
[TBL] [Abstract][Full Text] [Related]
30. Serum S100B levels correlate with stage, N status, mitotic rate and disease outcome in melanoma patients independent to LDH.
Karonidis A; Mantzourani M; Gogas H; Tsoutsos D
J BUON; 2017; 22(5):1296-1302. PubMed ID: 29135116
[TBL] [Abstract][Full Text] [Related]
31. Long-term survival is linked to serum LDH and partly to tumour LDH-5 in NSCLC.
Danner BC; Didilis VN; Wiemeyer S; Stojanovic T; Kitz J; Emmert A; Füzesi L; Schöndube FA
Anticancer Res; 2010 Apr; 30(4):1347-51. PubMed ID: 20530451
[TBL] [Abstract][Full Text] [Related]
32. Comparative study of YKL-40, S-100B and LDH as monitoring tools for Stage IV melanoma.
Egberts F; Kotthoff EM; Gerdes S; Egberts JH; Weichenthal M; Hauschild A
Eur J Cancer; 2012 Mar; 48(5):695-702. PubMed ID: 21917447
[TBL] [Abstract][Full Text] [Related]
33. Targeting metabolic flexibility by simultaneously inhibiting respiratory complex I and lactate generation retards melanoma progression.
Chaube B; Malvi P; Singh SV; Mohammad N; Meena AS; Bhat MK
Oncotarget; 2015 Nov; 6(35):37281-99. PubMed ID: 26484566
[TBL] [Abstract][Full Text] [Related]
34. Tyrosine phosphorylation of lactate dehydrogenase A is important for NADH/NAD(+) redox homeostasis in cancer cells.
Fan J; Hitosugi T; Chung TW; Xie J; Ge Q; Gu TL; Polakiewicz RD; Chen GZ; Boggon TJ; Lonial S; Khuri FR; Kang S; Chen J
Mol Cell Biol; 2011 Dec; 31(24):4938-50. PubMed ID: 21969607
[TBL] [Abstract][Full Text] [Related]
35. [Expression of lactate dehydrogenase-5 in non-Hodgkin lymphoma and its clinical significance].
Dong F; Sui A; Jing H
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Dec; 41(12):1312-1316. PubMed ID: 28070044
[TBL] [Abstract][Full Text] [Related]
36. The association between markers of tumour cell metabolism, the tumour microenvironment and outcomes in patients with colorectal cancer.
Roseweir AK; Clark J; McSorley ST; vanWyk HC; Quinn JA; Horgan PG; McMillan DC; Park JH; Edwards J
Int J Cancer; 2019 May; 144(9):2320-2329. PubMed ID: 30521130
[TBL] [Abstract][Full Text] [Related]
37. Lactate dehydrogenase 5 (LDH-5) expression in endometrial cancer relates to the activated VEGF/VEGFR2(KDR) pathway and prognosis.
Giatromanolaki A; Sivridis E; Gatter KC; Turley H; Harris AL; Koukourakis MI;
Gynecol Oncol; 2006 Dec; 103(3):912-8. PubMed ID: 16837029
[TBL] [Abstract][Full Text] [Related]
38. Metabolic approaches to treatment of melanoma.
Hersey P; Watts RN; Zhang XD; Hackett J
Clin Cancer Res; 2009 Nov; 15(21):6490-4. PubMed ID: 19861452
[TBL] [Abstract][Full Text] [Related]
39. Lactate Dehydrogenase and its clinical significance in pancreatic and thoracic cancers.
Comandatore A; Franczak M; Smolenski RT; Morelli L; Peters GJ; Giovannetti E
Semin Cancer Biol; 2022 Nov; 86(Pt 2):93-100. PubMed ID: 36096316
[TBL] [Abstract][Full Text] [Related]
40. Diagnostic and prognostic value of serum and peritoneal fluid lactate dehydrogenase in epithelial ovarian cancer.
Yüce K; Baykal C; Genç C; Al A; Ayhan A
Eur J Gynaecol Oncol; 2001; 22(3):228-32. PubMed ID: 11501779
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
